Foster & Motley’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGN
PCM
AA
Foster & Motley's OGN Position: Q2 2026 in Review
Foster & Motley reduced its Organon & Co (OGN) stake by 6% in Q2 2026, selling an estimated $9.8K and leaving 12,919 shares worth $175K. The position accounts for 0.01% of the portfolio, ranked #403.
Foster & Motley first reported a position in OGN in Q1 2022 and has held it in 18 quarters since. The position peaked at $1.24M in Q1 2023. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.
- Foster & Motley held 12,919 shares of Organon & Co worth $175K as of Q2 2026.
- Foster & Motley sold 820 Organon & Co shares in Q2 2026, an estimated $9.8K.
- Organon & Co made up 0.01% of Foster & Motley's portfolio in Q2 2026, its #403 holding.
- Foster & Motley first reported a position in Organon & Co in Q1 2022 and has held it in 18 quarters since.
- Foster & Motley's Organon & Co position peaked at $1.24M in Q1 2023.
- 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.
Based on Foster & Motley's 13F filing for Q2 2026, filed 7 Aug 2026.